Literature DB >> 14695627

Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study.

Jodi B Segal1, Neil R Powe.   

Abstract

Administrative data are commonly used to estimate the prevalence of a disease, but the validity of the coding system needs to be evaluated before its use. We assessed the validity of the International Classification of Disease, 9(th) version, Clinical Modification (ICD-9-CM) code of 287.3 for identifying patients with immune thrombocytopenic purpura (ITP). Administrative data from inpatients and outpatients seen were retrieved if the patient or insurer was billed with one of three ICD-9-CM codes for thrombocytopenic disorders, 287.3, 287.4, and 287.5, as a primary or secondary diagnosis; or was physician-identified as having ITP. The electronic medical records for these patients were systematically reviewed to identify patients with ITP and with non-ITP diagnoses. Sensitivity, specificity, positive and negative predictive values, and kappa scores were calculated separately for inpatients and outpatients. Four-hundred eighteen records were reviewed. Among inpatients, the sensitivity of code 287.3 for indicating a diagnosis of ITP was 100% [95% confidence interval 94-100%]. The specificity was 89% [95% confidence interval 84-94%]. The percent agreement was 92%, and the kappa statistic was 0.80. For outpatients, the sensitivity of the billing code 287.3 was 84% [95% confidence interval 76-91%], a conservative estimate because of how the patients with other diagnoses were selected. The specificity for outpatients was 66% [95% confidence interval 56-76%]. ICD-9-CM code 287.3 in administrative billing data is likely to be sufficiently sensitive and specific, particularly when inpatient data are used, for the estimation of the prevalence of ITP. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2004        PMID: 14695627     DOI: 10.1002/ajh.10445

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  11 in total

1.  Agreement of Medicaid claims and electronic health records for assessing preventive care quality among adults.

Authors:  John Heintzman; Steffani R Bailey; Megan J Hoopes; Thuy Le; Rachel Gold; Jean P O'Malley; Stuart Cowburn; Miguel Marino; Alex Krist; Jennifer E DeVoe
Journal:  J Am Med Inform Assoc       Date:  2014-02-07       Impact factor: 4.497

Review 2.  Epidemiology of primary immune thrombocytopenia in children and adults in Japan: a population-based study and literature review.

Authors:  Yoshiyuki Kurata; Kingo Fujimura; Masataka Kuwana; Yoshiaki Tomiyama; Mitsuru Murata
Journal:  Int J Hematol       Date:  2011-02-24       Impact factor: 2.490

3.  Combining structured and unstructured data to identify a cohort of ICU patients who received dialysis.

Authors:  Swapna Abhyankar; Dina Demner-Fushman; Fiona M Callaghan; Clement J McDonald
Journal:  J Am Med Inform Assoc       Date:  2014-01-02       Impact factor: 4.497

4.  Comorbidities in patients with persistent or chronic immune thrombocytopenia.

Authors:  Cheryl Enger; Dimitri Bennett; Ulla Forssen; Patrick F Fogarty; Andrew T McAfee
Journal:  Int J Hematol       Date:  2010-07-24       Impact factor: 2.490

5.  Determining a definite diagnosis of primary immune thrombocytopenia by medical record review.

Authors:  Deirdra R Terrell; Laura A Beebe; Sara K Vesely; Barbara R Neas; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2012-06-20       Impact factor: 10.047

6.  Prevalence of primary immune thrombocytopenia in Oklahoma.

Authors:  Deirdra R Terrell; Laura A Beebe; Barbara R Neas; Sara K Vesely; Jodi B Segal; James N George
Journal:  Am J Hematol       Date:  2012-06-05       Impact factor: 10.047

7.  Second-line treatments and outcomes for immune thrombocytopenia: A retrospective study with electronic health records.

Authors:  Lincy S Lal; Qayyim Said; Katherine Andrade; Adam Cuker
Journal:  Res Pract Thromb Haemost       Date:  2020-09-11

8.  Minimizing signal detection time in postmarket sequential analysis: balancing positive predictive value and sensitivity.

Authors:  Judith C Maro; Jeffrey S Brown; Gerald J Dal Pan; Martin Kulldorff
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-03       Impact factor: 2.890

9.  Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005-2010.

Authors:  Christina A Nelson; Shubhayu Saha; Kiersten J Kugeler; Mark J Delorey; Manjunath B Shankar; Alison F Hinckley; Paul S Mead
Journal:  Emerg Infect Dis       Date:  2015-09       Impact factor: 6.883

10.  Rate of bleeding-related episodes in adult patients with primary immune thrombocytopenia: a retrospective cohort study using a large administrative medical claims database in the US.

Authors:  Ivy Altomare; Karynsa Cetin; Sally Wetten; Jeffrey S Wasser
Journal:  Clin Epidemiol       Date:  2016-06-20       Impact factor: 4.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.